Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001101669.3(INPP4B):c.1862C>G(p.Thr621Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T621M) has been classified as Uncertain significance.
INPP4B (HGNC:6075): (inositol polyphosphate-4-phosphatase type II B) INPP4B encodes the inositol polyphosphate 4-phosphatase type II, one of the enzymes involved in phosphatidylinositol signaling pathways. This enzyme removes the phosphate group at position 4 of the inositol ring from inositol 3,4-bisphosphate. There is limited data to suggest that the human type II enzyme is subject to alternative splicing, as has been established for the type I enzyme. [provided by RefSeq, Jul 2008]
Loss of catalytic residue at T621 (P = 0.1646);Loss of catalytic residue at T621 (P = 0.1646);Loss of catalytic residue at T621 (P = 0.1646);Loss of catalytic residue at T621 (P = 0.1646);.;Loss of catalytic residue at T621 (P = 0.1646);.;